Susquehanna International Group
MAIA icon

Susquehanna International Group’s MAIA Biotechnology MAIA Stock Holding History

Susquehanna International Group’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,288
Closed -$21.9K – 13710
2025
Q4 		$21.9K Buy
14,288
+2,673
+23% +$3.49K ﹤0.01% 11937
2025
Q3 		$17.9K Buy
+11,615
New +$19K ﹤0.01% 12064
2025
Q2 		– Sell
-55,100
Closed -$84.3K – 13284
2025
Q1 		$84.3K Buy
55,100
+43,451
+373% +$80.4K ﹤0.01% 11644
2024
Q4 		$23.1K Buy
+11,649
New +$27.9K ﹤0.01% 11895

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group's MAIA Position: Q1 2026 in Review

Susquehanna International Group sold out of MAIA Biotechnology (MAIA) in Q1 2026, closing a stake of 14,288 shares — an estimated $21.9K sold.

Susquehanna International Group first reported a position in MAIA in Q4 2024 and held it in 4 quarters. The position peaked at $84.3K in Q1 2025. 33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

  • Susquehanna International Group reported no remaining MAIA Biotechnology position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 14,288 MAIA Biotechnology shares in Q1 2026, an estimated $21.9K.
  • Susquehanna International Group first reported a position in MAIA Biotechnology in Q4 2024 and held it in 4 quarters.
  • Susquehanna International Group's MAIA Biotechnology position peaked at $84.3K in Q1 2025.
  • 33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.